Inci et al., 2013 - Google Patents
Nanoplasmonic quantitative detection of intact viruses from unprocessed whole bloodInci et al., 2013
View HTML- Document ID
- 4622921937834850116
- Author
- Inci F
- Tokel O
- Wang S
- Gurkan U
- Tasoglu S
- Kuritzkes D
- Demirci U
- Publication year
- Publication venue
- ACS nano
External Links
Snippet
Infectious diseases such as HIV and hepatitis B pose an omnipresent threat to global health. Reliable, fast, accurate, and sensitive platforms that can be deployed at the point-of-care (POC) in multiple settings, such as airports and offices, for detection of infectious pathogens …
- 238000001514 detection method 0 title abstract description 128
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
- G01N33/56988—AIDS or HTLV
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/543—Immunoassay; Biospecific binding assay with an insoluble carrier for immobilising immunochemicals
- G01N33/54366—Apparatus specially adapted for solid-phase testing
- G01N33/54373—Apparatus specially adapted for solid-phase testing involving physiochemical end-point determination, e.g. wave-guides, FETS, gratings
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using infra-red, visible or ultra-violet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/645—Specially adapted constructive features of fluorimeters
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using infra-red, visible or ultra-violet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/65—Raman scattering
- G01N2021/653—Coherent methods [CARS]
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using infra-red, visible or ultra-violet light
- G01N21/75—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated
- G01N21/77—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated by observing the effect on a chemical indicator
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Inci et al. | Nanoplasmonic quantitative detection of intact viruses from unprocessed whole blood | |
| Chen et al. | Sensitive detection of SARS-CoV-2 using a SERS-based aptasensor | |
| Saylan et al. | An alternative medical diagnosis method: biosensors for virus detection | |
| Castillo-Henríquez et al. | Biosensors for the detection of bacterial and viral clinical pathogens | |
| Tsang et al. | Ultrasensitive detection of Ebola virus oligonucleotide based on upconversion nanoprobe/nanoporous membrane system | |
| Lifson et al. | Advances in biosensing strategies for HIV-1 detection, diagnosis, and therapeutic monitoring | |
| Wang et al. | Plasmonic metasurfaces for medical diagnosis applications: A review | |
| US10228372B2 (en) | Detection, capture and quantification of biological moieties from unprocessed bodily fluids using nanoplasmonic platform | |
| Lim et al. | Emerging biosensors to detect severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): a review | |
| Sharma et al. | Optical biosensors for diagnostics of infectious viral disease: A recent update | |
| Mousavi et al. | Highly sensitive flexible SERS-based sensing platform for detection of COVID-19 | |
| Misra et al. | Nanobiosensor‐based diagnostic tools in viral infections: Special emphasis on Covid‐19 | |
| Inci et al. | Enhancing the nanoplasmonic signal by a nanoparticle sandwiching strategy to detect viruses | |
| Serebrennikova et al. | Lateral flow immunoassay of SARS-CoV-2 antigen with SERS-based registration: development and comparison with traditional immunoassays | |
| Nath et al. | Detection of bacterial and viral pathogens using photonic point-of-care devices | |
| Rippa et al. | Octupolar plasmonic nanosensor based on ordered arrays of triangular Au nanopillars for selective rotavirus detection | |
| Zainol Abidin et al. | Current and potential developments of cortisol aptasensing towards point-of-care diagnostics (POTC) | |
| Nandi et al. | Biosensor platforms for rapid HIV detection | |
| JP2016507057A (en) | Inspection device | |
| Saraf et al. | Multiplex viral detection platform based on a aptamers-integrated microfluidic channel | |
| Li et al. | Affinity exploration of SARS-CoV-2 RBD variants to mAb-functionalized plasmonic metasurfaces for label-free immunoassay boosting | |
| Guo et al. | Highly sensitive fluorescence-linked immunosorbent assay for the determination of human IgG in serum using quantum dot nanobeads and magnetic Fe3O4 nanospheres | |
| Atta et al. | Dual-Modal Colorimetric and Surface-Enhanced Raman Scattering (SERS)-Based Lateral Flow Immunoassay for Ultrasensitive Detection of SARS-CoV-2 Using a Plasmonic Gold Nanocrown | |
| Xu et al. | Recent advances of representative optical biosensors for rapid and sensitive diagnostics of SARS-CoV-2 | |
| Kawasaki et al. | Imprinted photonic crystal-film-based smartphone-compatible label-free optical sensor for SARS-CoV-2 testing |